US02209S1033 - Common Stock - Premarket: 45.25 +0.21 (+0.47%)
Date | Firm | Action | Rating |
---|---|---|---|
2023-01-23 | Morgan Stanley | Maintains | Equal-Weight |
2022-11-10 | UBS | Downgrade | Neutral -> Sell |
2022-07-25 | Jefferies | Maintains | Buy |
2022-07-08 | B of A Securities | Maintains | Neutral |
2022-07-01 | Deutsche Bank | Maintains | Buy |
2022-06-29 | Barclays | Downgrade | Equal-Weight -> Underweight |
2022-06-27 | Cowen & Co. | Maintains | Market Perform |
2022-06-24 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
2022-06-17 | Morgan Stanley | Maintains | Underweight |
2022-06-08 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
2022-05-10 | Bernstein | Downgrade | Outperform -> Market Perform |
2022-05-02 | Morgan Stanley | Maintains | Equal-Weight |
2022-01-26 | Morgan Stanley | Maintains | Equal-Weight |
2022-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
2021-10-29 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
2021-06-17 | Redburn Partners | Initiate | Neutral |
2021-05-10 | Morgan Stanley | Maintains | Overweight |
2021-05-05 | Argus Research | Downgrade | Buy -> Hold |
2021-03-26 | Jefferies | Upgrade | Hold -> Buy |
2021-03-16 | Citigroup | Downgrade | Buy -> Neutral |
Find the competitors with the best analyst ratings on the USA